News

BONE THERAPEUTICS announces that it has signed the definitive subscription agreement for a maximum EUR 5 million convertible bonds (CBs) facility arranged by ABO Securities, through its…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda announced to transfer the marketing authorization in Japan for Moderna’s…
Read More...

NRG Therapeutics Ltd an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has received a highly competitive Biomedical Catalyst (BMC)…
Read More...

Novartis announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah (tisagenlecleucel) for the treatment of adult patients with relapsed or…
Read More...

Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier…
Read More...

Sirnaomics Ltd. a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the launch of a Phase I clinical trial of the Company's siRNA…
Read More...

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price…
Read More...

GSK plc announced that a two-dose schedule for its HPV vaccine Cervarix  has been approved by China’s NMPA for girls aged 9 to 14. With this approval, Cervarix is the first imported…
Read More...

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1 billion in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research…
Read More...

Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox. Hyundai Bioscience has decided to submit a request for a fast track…
Read More...

Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced that the U.S. Food and Drug Administration (FDA) approved TIBSOVO …
Read More...

Genomic Testing Cooperative (GTC) announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its liquid biopsy profiles for both solid tumors and…
Read More...

Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company using two lentiviral platforms to develop and commercialize therapies for genetic diseases, announced an…
Read More...

Cornerstone Pharmaceuticals, Inc. a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, announced that the European Medicines Agency (EMA) has…
Read More...

Halozyme Therapeutics, Inc. announced the successful completion of its acquisition of Antares Pharma, Inc. ("Antares"). The tender offer for all of the outstanding shares of Antares…
Read More...

A faculty member in the College of Pharmacy and Health Sciences at St. John’s University recently received a $492,000 federal grant to develop a COVID-19 vaccine that will be…
Read More...

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of a novel preclinical candidate (PCC)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy as…
Read More...

Ocugen, Inc. a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, announced that the U.S. Food and Drug…
Read More...

Biohaven Pharmaceutical Holding Company Ltd. announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review a New Drug Application (NDA) for zavegepant…
Read More...